亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Computed tomography radiomics prediction of survival in hepatocellular carcinoma and is associated with ADH1A expression of the retinol metabolism pathway

无线电技术 医学 肝细胞癌 接收机工作特性 内科学 肿瘤科 放射科
作者
Ting-Yu Yu,Ze-Juan Zhan,Qi Lin
出处
期刊:Medicine [Wolters Kluwer]
卷期号:104 (24): e42792-e42792
标识
DOI:10.1097/md.0000000000042792
摘要

The purpose of this study was to construct a prognostic model of hepatocellular carcinoma (HCC) patients based on radiomics features and to explore the corresponding mechanisms. Patients’ data and computed tomography images were collected from the Cancer Genome Atlas and the Cancer Imaging Archive. The radiomics features were extracted and screened via 3D Slicer and the Least Absolute Shrinkage and Selection Operator regression analysis for radiomics model construction, with rad score (RS) calculated. The net reclassification index, integrated discrimination improvement, receiver operating characteristic curve, and decision curve analysis were utilized to evaluate the prediction efficiency of the model. Restricted Cubic Splines and Kaplan–Meier were used to analyze the association between RS and overall survival (OS). The differentially expressed genes between the high- and low-RS groups were collected for enrichment analyses to screen the key pathways and core genes. Based on 4 key features associated with OS, a model was constructed: RS = 0.626* Gray Level Nonuniformity Normalized + 0.063*Dependence Nonuniformity Normalized - 0.253* Long Run Low Gray Level Emphasis - 35.93* Contrast. The radiomics model had superior performance in predicting OS, and high RS was associated with poor OS ( P < .05). Moreover, RS may influence HCC prognosis through ADH1A regulation of the retinol metabolism pathway. The prognostic model based on radiomics features has good predictive performance in HCC patients. The RS model may promote HCC progression through ADH1A regulation of the retinol metabolism pathway.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刻苦羽毛完成签到 ,获得积分10
45秒前
haralee完成签到 ,获得积分10
1分钟前
2分钟前
Su完成签到 ,获得积分10
2分钟前
xiaoder发布了新的文献求助10
2分钟前
z脏脏包完成签到 ,获得积分10
2分钟前
2分钟前
2025211022完成签到,获得积分20
2分钟前
2025211022发布了新的文献求助10
2分钟前
3分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
3分钟前
村口的帅老头完成签到 ,获得积分0
3分钟前
科研通AI6.1应助houyuhao123123采纳,获得30
4分钟前
ffff完成签到 ,获得积分10
4分钟前
4分钟前
5分钟前
5分钟前
5分钟前
ZZZ发布了新的文献求助10
5分钟前
ZZZ完成签到,获得积分10
6分钟前
卤肉饭与石榴汁完成签到,获得积分10
6分钟前
meeteryu完成签到,获得积分10
6分钟前
6分钟前
pete完成签到,获得积分10
6分钟前
George完成签到,获得积分10
7分钟前
江水边完成签到 ,获得积分10
7分钟前
7分钟前
8分钟前
科研通AI6.2应助ben采纳,获得10
9分钟前
9分钟前
ben发布了新的文献求助10
9分钟前
Abdurrahman完成签到,获得积分10
9分钟前
9分钟前
大模型应助科研通管家采纳,获得10
9分钟前
zx发布了新的文献求助20
10分钟前
Wang完成签到 ,获得积分20
10分钟前
10分钟前
赘婿应助ben采纳,获得10
10分钟前
10分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Treatment of refractory idiopathic overactive bladder with incobotulinumtoxinA and vibe delivery system (XAVIER): pilot study 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6947951
求助须知:如何正确求助?哪些是违规求助? 8632781
关于积分的说明 18307715
捐赠科研通 6386557
什么是DOI,文献DOI怎么找? 3080694
关于科研通互助平台的介绍 2123694
邀请新用户注册赠送积分活动 2057586